Slow metabolism 'obesity excuse' true
By James Gallagher Health
http://www.bbc.co.uk/news/health-24610296
The mocked "obesity excuse" of being born with a slow metabolism is actually true for some people, say researchers.
A team at the University of Cambridge has found the first proof that mutated DNA does indeed slow metabolism.
The researchers say fewer than one in 100 people are affected and are often severely obese by early childhood.
The findings, published in the journal Cell, may lead to new obesity treatments even for people without the mutation.
Scientists at the Institute of Metabolic Science, in Cambridge, knew that mice born without a section of DNA, a gene called KSR2, gained weight more easily.
But they did not know what effect it may be having in people, so they analysed the DNA of 2,101 severely obese patients.
Some had mutated versions of KSR2.
It had a twin effect of increasing their appetite while their slowing metabolism.
"You would be hungry and wanting to eat a lot, you would not want to move because of a slower metabolism and would probably also develop type 2 diabetes at a young age," lead researcher Prof Sadaf Farooqi told the BBC.
She added: "It slows the ability to burn calories and that's important as it's a new explanation for obesity."
The mutation delivers a double-whammy by increasing the drive to eat and reducing calorie burn
Rare
KSR2 is mostly active in the brain and it affects the way individual cells interpret signals, such as the hormone insulin, from the blood. This in turn affects the body's ability to burn calories.
Prof Farooqi said the metabolism argument had been derided by doctors, as well as wider society, due to a lack of evidence that metabolism was slowed in obese patients. In many cases obese patients have an elevated metabolism to cope with fuelling a much larger body.
She said less than 1% of people had mutated versions of the gene and some would be a normal weight, but about 2% of children who were obese by the age of five would have the mutated gene.
However, if drugs could be developed to target problems with KSR2, then it might be beneficial to anyone who is too fat.
"Other genetic disorders, such as in blood pressure, have shown that even where there's a normal gene, targeting the pathway can still help," Prof Farooqi said.
The amount and types of food eaten, as well as levels of exercise, directly affect weight, but some people at more risk of becoming obese that others.
Obesity can run in families. The other obesity genes that have been discovered tend to affect appetite.
People have two copies of the FTO gene - one from each parent - and each copy comes in a high- and a low-risk form. Those with two-high risk copies of the FTO gene are thought to be 70% more likely to become obese than those with low-risk genes.
It makes fatty foods more tempting and alters levels of the hunger hormone ghrelin.
Dr Katarina Kos, from the University of Exeter Medical School, said: "It is an exciting and interesting breakthrough, this is a new pathway predisposing people to obesity.
"But it does exist in obese and lean people so you still need the obesogenic environment."
By James Gallagher Health
http://www.bbc.co.uk/news/health-24610296
The mocked "obesity excuse" of being born with a slow metabolism is actually true for some people, say researchers.
A team at the University of Cambridge has found the first proof that mutated DNA does indeed slow metabolism.
The researchers say fewer than one in 100 people are affected and are often severely obese by early childhood.
The findings, published in the journal Cell, may lead to new obesity treatments even for people without the mutation.
Scientists at the Institute of Metabolic Science, in Cambridge, knew that mice born without a section of DNA, a gene called KSR2, gained weight more easily.
But they did not know what effect it may be having in people, so they analysed the DNA of 2,101 severely obese patients.
Some had mutated versions of KSR2.
It had a twin effect of increasing their appetite while their slowing metabolism.
"You would be hungry and wanting to eat a lot, you would not want to move because of a slower metabolism and would probably also develop type 2 diabetes at a young age," lead researcher Prof Sadaf Farooqi told the BBC.
She added: "It slows the ability to burn calories and that's important as it's a new explanation for obesity."
The mutation delivers a double-whammy by increasing the drive to eat and reducing calorie burn
Rare
KSR2 is mostly active in the brain and it affects the way individual cells interpret signals, such as the hormone insulin, from the blood. This in turn affects the body's ability to burn calories.
Prof Farooqi said the metabolism argument had been derided by doctors, as well as wider society, due to a lack of evidence that metabolism was slowed in obese patients. In many cases obese patients have an elevated metabolism to cope with fuelling a much larger body.
She said less than 1% of people had mutated versions of the gene and some would be a normal weight, but about 2% of children who were obese by the age of five would have the mutated gene.
However, if drugs could be developed to target problems with KSR2, then it might be beneficial to anyone who is too fat.
"Other genetic disorders, such as in blood pressure, have shown that even where there's a normal gene, targeting the pathway can still help," Prof Farooqi said.
The amount and types of food eaten, as well as levels of exercise, directly affect weight, but some people at more risk of becoming obese that others.
Obesity can run in families. The other obesity genes that have been discovered tend to affect appetite.
People have two copies of the FTO gene - one from each parent - and each copy comes in a high- and a low-risk form. Those with two-high risk copies of the FTO gene are thought to be 70% more likely to become obese than those with low-risk genes.
It makes fatty foods more tempting and alters levels of the hunger hormone ghrelin.
Dr Katarina Kos, from the University of Exeter Medical School, said: "It is an exciting and interesting breakthrough, this is a new pathway predisposing people to obesity.
"But it does exist in obese and lean people so you still need the obesogenic environment."
